1. MichailovaKN, UsunoffKG. Serosal membranes (pleura, pericardium, peritoneum). Normal structure, development and experimental pathology. Adv Anat Embryol Cell Biol2006;183:i.

2. GalachM, WerynskiA, WaniewskiJ, et al.Kinetic analysis of peritoneal fluid and solute transport with combination of glucose and icodextrin as osmotic agents. Perit Dial Int2009;29:72.

3. BaczyŃskiD, AntosiewiczS, WaniewskiJ, et al.Transperitoneal transport of water and substances–between theory and practice. Pol Merkur Lekarski2006;21:192.

4. RosengrenB, SagstadS, KarlsenT, et al.Isolation of interstitial fluid and demonstration of local proinflammatory cytokine production and increased absorptive gradient in chronic peritoneal dialysis. Am J Physiol Renal Physiol2013;304:F198. CrossRef

5. CoronelF, CigarranS, GomisA, et al.Changes in peritoneal membrane permeability and proteinuria in patients on peritoneal dialysis after treatment with paricalcitol‐ a preliminary study. Clin Nephrol2012;78:93. CrossRef

6. UenoT, NakashimaA, DoiS, et al.Mesenchymal stem cells ameliorate experimental peritoneal fibrosis by suppressing inflammation and inhibiting TGF‐β1 signaling. Kidney Int2013;84:297. CrossRef

7. KazanciogluR. Peritoneal defense mechanisms–the effects of new peritoneal dialysis solutions. Perit Dial Int2009;29:S198.

8. Shalimar, AcharyaSK. Difficult to treat spontaneous bacterial peritonitis. Trop Gastroenterol2013;34:7. CrossRef

9. NeffG, KemmerN, DuncanC, et al.Update on the management of cirrhosis‐ focus on cost‐effective preventative strategies. Clinicoecon Outcomes Res2013;5:143. CrossRef

10. CaruntuF, BeneaL. Spontaneous bacterial peritonitis: pathogenesis, diagnosis, treatment. J Gastrointestin Liver Dis2006;15:51.

11. MarshallJ. Intra‐abdominal infections. Microbes Infect2004;6:1015. CrossRef

12. SudingP, OrricoR, JohnsonS, et al.Concordance of interrater assessments of surgical methods to achieve source control of intra‐abdominal infections. Am J Surg2008;196:70. CrossRef

13. OzgüçH, YilmazlarT, GürlülerE, et al.Staged abdominal repair in the treatment of intra‐abdominal infection: analysis of 102 patients. J Gastrointest Surg2003;7:646. CrossRef

14. JonesR. Recognition of pneumoperitoneum using bedside ultrasound in critically ill patients presenting with acute abdominal pain. Am J Emerg Med2007;25:838. CrossRef

15. ImutaM, AwaiK, NakayamaY, et al.Multidetector CT findings suggesting a perforation site in the gastrointestinal tract: analysis in surgically confirmed 155 patients. Radiat Med2007;25:113. CrossRef

16. FurukawaA, SakodaM, YamasakiM, et al.Gastrointestinal tract perforation: CT diagnosis of presence, site, and cause. Abdom Imaging2005;30:524. CrossRef

17. SchietromaM, PiccioneF, CarleiF, et al.Peritonitis from perforated appendicitis: stress response after laparoscopic or open treatment. Am Surg2012;78:582.

18. SawayamaH, TomiyasuS, KanemitsuK, et al.Colonic perforation due to colorectal cancer: predicting postoperative organ failure with a preoperative scoring system and selecting the optimal surgical method based on the prognosis. Surg Today2012;42:1082. CrossRef

19. DysonA, RudigerA, SingerM. Temporal changes in tissue cardiorespiratory function during faecal peritonitis. Intensive Care Med2011;37:1192. CrossRef

20. LoboS, RezendeE, KnibelM, et al.Early determinants of death due to multiple organ failure after noncardiac surgery in high‐risk patients. Anesth Analg2011;112:877. CrossRef

21. DellingerR, LevyM, RhodesA. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med2013;39:165. CrossRef

22. SolomkinJ, MazuskiJ, BradleyJ, et al.Diagnosis and management of complicated intra‐abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis2010;50:133. CrossRef

23. NadlerE, GainesB, Therapeutic ACotSIS. The Surgical Infection Society guidelines on antimicrobial therapy for children with appendicitis. Surg Infect (Larchmt)2008;9:75. CrossRef

24. WongP, GilliamA, KumarS, et al.Antibiotic regimens for secondary peritonitis of gastrointestinal origin in adults. Cochrane Database Syst Rev2005;(2):CD004539.

25. WeledjiE, NgoweM. The challenge of intra‐abdominal sepsis. Int J Surg2013;11:290. CrossRef

26. SwankH, MulderI, HoofwijkA, et al.Early experience with laparoscopic lavage for perforated diverticulitis. Br J Surg2013;100:704. CrossRef

27. AgrestaF, CiardoL, MazzaroloG, et al.Peritonitis: laparoscopic approach. World J Emerg Surg2006;1:9. CrossRef

28. ManciniG, ManciniM, NelsonHSJr. Efficacy of laparoscopic appendectomy in appendicitis with peritonitis. Am Surg2005;71:1.

29. AbrahamE, AnzuetoA, GutierrezG, et al.Double‐blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. Lancet1998;351:929. CrossRef

30. SprungC, FinchR, ThijsL, et al.International sepsis trial (INTERSEPT): role and impact of a clinical evaluation committee. Crit Care Med1996;24:1441. CrossRef

31. RiversE, JaehneA, NguyenH. Early biomarker activity in severe sepsis and septic shock and a contemporary review of immunotherapy trials: not a time to give up, but to give it earlier. Shock2013;39:127.

32. BoL, WangF, ZhuJ, et al.Granulocyte‐colony stimulating factor (G‐CSF) and granulocyte‐macrophage colony stimulating factor (GM‐CSF) for sepsis: a meta‐analysis. Crit Care2011;15:R58. CrossRef

33. AnnaneD, TimsitJ, MegarbaneB, et al.Recombinant human activated protein C for adults with septic shock: a randomized controlled trial. Am J Respir Crit Care Med2013;187:1091. CrossRef

34. RanieriV, ThompsonB, FinferS, et al.Unblinding plan of PROWESS‐SHOCK trial. Intensive Care Med2011;37:1384. CrossRef

35. ChalyaP, MchembeM, MshanaS, et al.Clinicopathological profile and surgical treatment of abdominal tuberculosis: a single centre experience in northwestern Tanzania. BMC Infect Dis2013;13:270. CrossRef

36. CamargoM, VenturiniJ, Vilani‐MorenoF, et al.Modulation of macrophage cytokine profiles during solid tumor progression: susceptibility to Candida albicans infection. BMC Infect Dis2009;9:98. CrossRef

37. LiuS, ChernC, YenD, et al.Abdominal wall and intraperitoneal absceses complicating Aspergillus peritonitis in peritoneal dialysis. Am J Med Sci2009;337:56. CrossRef

38. GoelMM, VermaN, SagarM. Disseminated intra‐abdominal hydatidosis causing acute intestinal obstruction–a rare presentation. BMJ Case Rep2010;2010 pii: bcr0620103066.

39. TinkerM, BurdmanD, DeysineM, et al.Granulomatous peritonitis due to cellulose fibers from disposable surgical fabrics: laboratory investigation and clinical implications. Ann Surg1974;180:831. CrossRef

40. SègaardO, ReekieJ, RistolaM, et al.Severe bacterial non‐aids infections in HIV‐positive persons: incidence rates and risk factors. J Infect2013;66:439. CrossRef

41. SaracinoA, TartagliaA, TrilloG, et al.Late presentation and loss to follow‐up of immigrants newly diagnosed with HIV in the HAART era. J Immigr Minor Health2014;16:751. CrossRef

42. VissmanA, YoungA, WilkinA, et al.Correlates of HAART adherence among immigrant Latinos in the southeastern United States. AIDS Care2013;25:356.

43. ChakrobortyA. Drug‐resistant tuberculosis: an insurmountable epidemic?Inflammopharmacology2011;19:131. CrossRef

44. AkoloC, AdetifaI, ShepperdS, et al.Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev2010;(1):CD000171.

45. NorbisL, MiottoP, AlagnaR, et al.Tuberculosis: lights and shadows in the current diagnostic landscape. New Microbiol2013;36:111.

46. PangY, LiQ, OuX, et al.Cost‐effectiveness comparison of genechip and conventional drug susceptibility test for detecting multidrug‐resistant tuberculosis in China. PLoS ONE2013;8:e69267. CrossRef

47. BassiliA, FitzpatrickC, QadeerE, et al.A systematic review of the effectiveness of hospital‐ and ambulatory‐based management of multidrug‐resistant tuberculosis. Am J Trop Med Hyg2013;89:271. CrossRef

48. SanaiF, BzeiziK. Systematic review: tuberculous peritonitis _ presenting features, diagnostic strategies and treatment. Aliment Pharmacol Ther2005;22:685. CrossRef

49. TsengW, TarngD. Cocoon‐like fibroadhesive tuberculous peritonitis in a peritoneal dialysis patient. Chin J Physiol2012;55:361.

50. KhanR, AbidS, JafriW, et al.Diagnostic dilemma of abdominal tuberculosis in non‐HIV patients: an ongoing challenge for physicians. World J Gastroenterol2006;12:6371.

51. SheerT, CoyleW. Gastrointestinal tuberculosis. Curr Gastroenterol Rep2003;5:273. CrossRef

52. KimH, PrithivirajK, GroathouseN, et al.Gene expression profile and immunological evaluation of unique hypothetical unknown proteins of Mycobacterium leprae by using quantitative real‐time PCR. Clin Vaccine Immunol2013;20:181. CrossRef

53. KocamanO, DanalioğluA, İnceA, et al.Diagnosis of tuberculous peritonitis using endoscopic ultrasound‐guided fine‐needle aspiration biopsy of the peritoneum. Turk J Gastroenterol2013;24:65.

54. KrishnanP, VayothS, DharP, et al.Laparoscopy in suspected abdominal tuberculosis is useful as an early diagnostic method. ANZ J Surg2008;78:987. CrossRef

55. BlumbergH, LeonardMJr, JasmerR. Update on the treatment of tuberculosis and latent tuberculosis infection. JAMA2005;293:2776. CrossRef

56. DuanY, YangB, ZhuF. Traumatic rupture of a type IVa choledochal cyst in an adult male. World J Gastroenterol2013;19:3911. CrossRef

57. PetrosyanE, TereshenkoO, BotashevA, et al.Role of endothelial dysfunction and lymphocyte‐platelet adhesion in the pathogenesis of bile peritonitis. Bull Exp Biol Med2013;154:428. CrossRef

58. FathyO, WahabM, HamdyE, et al.Post‐cholecystectomy biliary injuries: one center experience. Hepatogastroenterology2011;58:719.

59. MatlockK, TyrochA, KronfolZ, et al.Blunt traumatic bladder rupture: a 10‐year perspective. Am Surg2013;79:589.

60. VettorettoN, OdehM, RomessisM, et al.Acute abdomen from chylous peritonitis: a surgical diagnosis (Case report and literature review). Eur Surg Res2008;41:54. CrossRef

61. TurbendianHK, ShouJ, BariePS. Barium peritonitis. Surg Infect (Larchmt)2013;14:561. CrossRef

62. KitajimaT, TomizawaK, HanaokaY, et al.Anastomotic stenosis of the descending colon caused by barium granuloma formation following barium peritonitis: report of a case. Surg Today2014;44:2153. CrossRef

63. SegalJ, MessanaJ. Prevention of peritonitis in peritoneal dialysis. Semin Dial2013;26:494. CrossRef

64. VargemezisV, ThodisE. Prevention and management of peritonitis and exit‐site infection in patients on continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant2001;16:106. CrossRef

65. GardenierJ, SawyerR, SifriC, et al.Peritonitis caused by Haemophilus parainfluenzae, Leifsonia aquatica, and Gordonia spp in a patient undergoing continuous ambulatory peritoneal dialysis. Surg Infect (Larchmt)2012;13:409. CrossRef

66. NessimS, KomendaP, RigattoC, et al.Frequency and microbiology of peritonitis and exit‐site infection among obese peritoneal dialysis patients. Perit Dial Int2013;33:167. CrossRef

67. TeitelbaumI, BurkartJ. Peritoneal dialysis. Am J Kidney Dis2003;42:1082. CrossRef

68. LopesK, RochaA, RodriguesA, et al.Long‐term peritoneal dialysis experience: quality control supports the use of fluconazole to prevent fungal peritonitis. Int J Artif Organs2013;36:484. CrossRef

69. RocklinM, TeitelbaumI. Noninfectious causes of cloudy peritoneal dialysate. Semin Dial2001;14:37. CrossRef

70. BaroneR, CámporaM, GimenezN, et al.Continuous ambulatory peritoneal dialysis versus automated peritoneal dialysis and peritonitis in the short and very long term at risk. Adv Perit Dial2012;28:44.

71. GoldbergL, ClemengerM, AzadianB, et al.Initial treatment of peritoneal dialysis peritonitis without vancomycin with a once‐daily cefazolin‐based regimen. Am J Kidney Dis2001;37:49. CrossRef

72. KeaneW, BailieG, BoeschotenE, et al.Adult peritoneal dialysis‐related peritonitis treatment recommendations: 2000 update. Perit Dial Int2000;20:396.

73. ClarkeD, ThomsonS, BissettyT, et al.A single surgical unit's experience with abdominal tuberculosis in the HIV/AIDS era. World J Surg2007;31:1087. CrossRef

74. TaurY, PamerE. The intestinal microbiota and susceptibility to infection in immunocompromised patients. Curr Opin Infect Dis2013;26:332. CrossRef

75. DimitroulisD, ValsamiS, SpartalisE, et al.Hepatocellular carcinoma in patients co‐infected with hepatitis C virus and human immunodeficiency virus. World J Hepatol2013;5:323.

76. TsaiH, LeeS, WannS, et al.Colon perforation with peritonitis in an acquired immunodeficiency syndrome patient due to cytomegalovirus and amoebic colitis. J Formos Med Assoc2005;104:839.

77. OhashiN, IsozakiT, ShirakawaK, et al.Cytomegalovirus colitis following immunosuppressive therapy for lupus peritonitis and lupus nephritis. Intern Med2003;42:362. CrossRef

78. Naufal SpirPR, Zampieri D'AndreaL, FonsecaE, et al.Epidemiology of human immunodeficiency virus‐visceral leishmaniasis‐co‐infection. J Microbiol Immunol Infect2013; doi: 10.1016/j.jmii.2013.05.002. [Epub ahead of print].

79. Al‐HasanM, McCormickM, RibesJ. Invasive enteric infections in hospitalized patients with underlying strongyloidiasis. Am J Clin Pathol2007;128:622. CrossRef

80. El‐KershK, RawasiaW, ChaddhaU, et al.Rarity revisited: cryptococcal peritonitis. BMJ Case Rep2013;2013 pii: bcr2013009099.

81. CadbyG, MukherjeeS, MuskAW, et al.A genome‐wide association study for malignant mesothelioma risk. Lung Cancer2013;82:1. CrossRef

82. VandermeersF, Neelature SriramareddyS, CostaC, et al.The role of epigenetics in malignant pleural mesothelioma. Lung Cancer2013;81:311. CrossRef

83. TurnerK, VargheseS, AlexanderHRJr. Current concepts in the evaluation and treatment of patients with diffuse malignant peritoneal mesothelioma. J Natl Compr Canc Netw2012;10:49.

84. PedataP, FeolaD, LaietaM, et al.Peritoneal mesothelioma: descritption of a case and review of the literature. Int J Immunopathol Pharmacol2011;24:85S.

85. BourgaultMH, GagneM, ValckeM. Lung cancer and mesothelioma risk assessment for a population environmentally exposed to asbestos. Int J Hyg Environ Health2014;217:340. CrossRef

86. AndujarP, PaironJ, RenierA, et al.Differential mutation profiles and similar intronic TP53 polymorphisms in asbestos‐related lung cancer and pleural mesothelioma. Mutagenesis2013;28:323. CrossRef

87. AstoulP, RocaE, Galateau‐SalleF, et al.Malignant pleural mesothelioma: from the bench to the bedside. Respiration2012;83:481. CrossRef

88. ClarkJ, RossW. An unusual case of ascites: pitfalls in diagnosis of malignant peritoneal mesothelioma. Aust N Z J Surg2012;70:384. CrossRef

89. WhitakerD. The cytology of malignant mesothelioma. Cytopathology2000;11:139. CrossRef

90. LintonA, KaoS, VardyJ, et al.Immunohistochemistry in the diagnosis of malignant pleural mesothelioma: trends in Australia and a literature review. Asia Pac J Clin Oncol2012;9:273. CrossRef

91. SusterS, MoranC. Applications and limitations of immunohistochemistry in the diagnosis of malignant mesothelioma. Adv Anat Pathol2006;13:316. CrossRef

92. Ramos‐NinoM, TestaJ, AltomareD, et al.Cellular and molecular parameters of mesothelioma. J Cell Biochem2006;98:723. CrossRef

93. ChewS, OkazakiY, NagaiH. Cancer‐promoting role of adipocytes in asbestos‐induced mesothelial carcinogenesis through dysregulated adipocytokine production. Carcinogenesis2014;35:164. CrossRef

94. Neragi‐MiandoabS, SugarbakerD. Chromosomal deletion in patients with malignant pleural mesothelioma. Interact Cardiovasc Thorac Surg2009;9:42. CrossRef

95. De RienzoA, JhanwarS, TestaJ. Loss of heterozygosity analysis of 13q and 14q in human malignant mesothelioma. Genes Chromosomes Cancer2000;28:337. CrossRef

96. GirardelliM, MaestriI, RinaldiR, et al.NLRP1 polymorphisms in patients with asbestos‐associated mesothelioma. Infect Agent Cancer2012;7:25. CrossRef

97. KleinG, PowersA, CroceC. Association of SV40 with human tumors. Oncogene2002;21:1141. CrossRef

98. Garcia‐CarboneroR, Paz‐AresL. Systemic chemotherapy in the management of malignant peritoneal mesothelioma. Eur J Surg Oncol2006;32:676. CrossRef

99. JanneP. Chemotherapy for malignant pleural mesothelioma. Clin Lung Cancer2003;5:98. CrossRef

100. BarattiD, KusamuraS, CabrasAD, et al.Diffuse malignant peritoneal mesothelioma: long‐term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC). Eur J Cancer2013;49:3140. CrossRef

101. VotanopoulosK, NewmanN, RussellG, et al.Outcomes of cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients older than 70 years; survival benefit at considerable morbidity and mortality. Ann Surg Oncol2013;20:3497. CrossRef

102. XiaH, KarasawaK, HanyuN, et al.Hyperthermia combined with intra‐thoracic chemotherapy and radiotherapy for malignant pleural mesothelioma. Int J Hyperthermia2006;22:613. CrossRef

103. HaasA, StermanD. Malignant pleural mesothelioma: update on treatment options with a focus on novel therapies. Clin Chest Med2013;34:99. CrossRef

104. MukherjeeS, HaenelT, HimbeckR, et al.Replication‐restricted vaccinia as a cytokine gene therapy vector in cancer: persistent transgene expression despite antibody generation. Cancer Gene Ther2000;7:663. CrossRef

105. TadaY, ShimadaH, HiroshimaK, et al.A potential therapeutic strategy for malignant mesothelioma with gene medicine. Biomed Res Int2013;2013:572609. CrossRef

106. NikolicO, DjurdjevicS, StojanovicS, et al.Pseudomyxoma peritonei–case report. Eur J Gynaecol Oncol2012;33:227.

107. ShettyS, ThomasP, RamananB, et al.Kras mutations and p53 overexpression in pseudomyxoma peritonei: association with phenotype and prognosis. J Surg Res2013;180:97. CrossRef

108. HopkinsM, DepetrilloA, LeT, et al.Pseudomyxoma peritonei: a case series and review of the literature. Int J Gynecol Cancer2005;15:32. CrossRef

109. BradleyR, StewartJ4th, RussellG, et al.Pseudomyxoma peritonei of appendiceal origin: a clinicopathologic analysis of 101 patients uniformly treated at a single institution, with literature review. Am J Surg Pathol2006;30:551. CrossRef

110. CarrN, FinchJ, IlesleyI, et al.Pathology and prognosis in pseudomyxoma peritonei: a review of 274 cases. J Clin Pathol2012;65:919. CrossRef

111. LowR, SebrechtsC, BaroneR, et al.Diffusion‐weighted MRI of peritoneal tumors: comparison with conventional MRI and surgical and histopathologic findings–a feasibility study. AJR Am J Roentgenol2009;193:461. CrossRef

112. KusamuraS, HutanuI, BarattiD, et al.Circulating tumor markers: predictors of incomplete cytoreduction and powerful determinants of outcome in pseudomyxoma peritoneii. J Surg Oncol2013;108:1. CrossRef

113. SmeenkR, VerwaalV, AntoniniN, et al.Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg2007;245:104. CrossRef

114. JacqueminG, LalouxP. Pseudomyxoma peritonei: review on a cluster of peritoneal mucinous diseases. Acta Chir Belg2005;105:127.

115. HussainN, HanscomD, OskouianRJr. Chyloretroperitoneum following anterior spinal surgery. J Neurosurg Spine2012;17:415. CrossRef

116. KenneyP, TuerkI. Complications of laparoscopic retroperitoneal lymph node dissection in testicular cancer. World J Urol2008;26:561. CrossRef

117. YeungL, BrandesS. Contemporary management of renal trauma: differences between urologists and trauma surgeons. J Trauma Acute Care Surg2012;72:68.

118. TaiD, LiW, LeeK, et al.Retroperitoneal pelvic packing in the management of hemodynamically unstable pelvic fractures: a level I trauma center experience. J Trauma2011;71:E79. CrossRef

119. WallaceG, StarnesB, HatsukamiT, et al.Favorable discharge disposition and survival after successful endovascular repair of ruptured abdominal aortic aneurysm. J Vasc Surg2013;57:1495. CrossRef

120. IvascuF, JanczykR, BairH, et al.Spontaneous retroperitoneal hemorrhage. Am J Surg2005;189:345. CrossRef

121. BodheyN, GuptaA, SreedharR, et al.Retroperitoneal hematoma: an unusual complication after femoral vein cannulation. J Cardiothorac Vasc Anesth2006;20:859. CrossRef

122. TalmorM, FaheyTJ2nd, WiseJ, et al.Large‐volume liposuction complicated by retroperitoneal hemorrhage: management principles and implications for the quality improvement process. Plast Reconstr Surg2000;105:2244. CrossRef

123. WongOF, HoPL, LamSK. Retrospective review of clinical presentations, microbiology, and outcomes of patients with psoas abscess. Hong Kong Med J2013;19:416.

124. YagmurdurM, AkbulutS, ColakA, et al.Retroperitoneal fibrosis and obstructive uropathy due to actinomycosis: case report of a treatment approach. Int Surg2009;94:283.

125. VaidyaR, SwetzK. Urinoma presenting as an abscess in an immunocompromised host: a case report. J Med Case Rep2013;7:193. CrossRef

126. XuH, LiX, ZhangZ, et al.Visualization of the left extraperitoneal space and spatial relationships to its related spaces by the visible human project. PLoS ONE2011;6:e27166. CrossRef

127. LeeJ, KwakK, ParkJ, et al.The efficacy of nonsurgical treatment of infected pancreatic necrosis. Pancreas2007;34:399. CrossRef

128. MeenaS, MittalS, ChowdharyB. Spinal tuberculosis: which is the best surgical approach?Med Princ Pract2014;23:96. CrossRef

129. HaddadN, AndonianS, AnidjarM. Simultaneous bilateral subcutaneous pyelovesical bypass as a salvage procedure in refractory retroperitoneal fibrosis. Can Urol Assoc J2013;7:E417.

130. VivasI, NicolásA, VelázquezP, et al.Retroperitoneal fibrosis: typical and atypical manifestations. Br J Radiol2000;73:214. CrossRef

131. ScheelPJJr, FeeleyN. Retroperitoneal fibrosis. Rheum Dis Clin North Am2013;39:365. CrossRef

132. AkbalC, TanidirY, OzgenM, et al.Erectile dysfunction and Peyronie's disease in patient with retroperitoenal fibrosis. Int Urol Nephrol2008;40:971. CrossRef

133. Castro‐IglesiasN, Belhassen‐GarcêaM, Velasco‐TiradoV, et al.Ormond's disease: experience with five cases. Reumatol Clin2010;6:199. CrossRef

134. ComingsD, SkubiK, Van EyesJ, et al.Familial multifocal fibrosclerosis: findings suggesting that retroperitoneal fibrosis, mediastinal fibrosis, sclerosing cholangitis, Riedelês thyroiditis, and pseudotumor of the orbit may be different manifestations of a single disease. Ann Intern Med1967;66:884. CrossRef

135. PizziniA, CorradoS, RadighieriE, et al.Hashimoto's thyroiditis associated with idiopathic retroperitoneal fibrosis: case report and review of the literature. Int J Clin Pract2007;61:162. CrossRef

136. CaiF, TesarP, KlestovA. Methysergide‐induced retroperitoneal fibrosis and pericardial effusion. Intern Med J2004;34:297. CrossRef

137. AhmadS. Association of metoprolol and retroperitoneal fibrosis. Am Heart J1996;131:202. CrossRef

138. RehringT, BrewsterD, KaufmanJ, et al.Regression of perianeurysmal fibrosis and ureteral dilation following endovascular repair of inflammatory abdominal aortic aneurysm. Ann Vasc Surg2001;15:591. CrossRef

139. AissiK, RossiP, DemouxA, et al.Endovascular treatment of iliocaval occlusion due to idiopathic retroperitoneal fibrosis. Eur J Intern Med2004;15:534. CrossRef

140. LeoneJ, Nguyen‐MinhN, LeeD, et al.Retroperitoneal fibrosis: a report of complete colonic obstruction. Am Surg1997;63:475.

141. MatsushitaM, FukuiT, UchidaK, et al.Atypical retroperitoneal fibrosis associated with biliary stricture: IgG4‐related sclerosing disease?Scand J Gastroenterol2009;44:1146. CrossRef

142. GeogheganT, ByrneA, BenfayedW, et al.Imaging and intervention of retroperitoneal fibrosis. Australas Radiol2007;51:26. CrossRef

143. CaiafaR, VinuesaA, IzquierdoR, et al.Retroperitoneal fibrosis: role of imaging in diagnosis and follow‐up. Radiographics2013;33:535. CrossRef

144. MirilasP, SkandalakisJ. Surgical anatomy of the retroperitoneal spaces part II: the architecture of the retroperitoneal space. Am Surg2010;76:33.

145. MiraultT, LambertM, PuechP, et al.Malignant retroperitoneal fibrosis: MRI characteristics in 50 patients. Medicine (Baltimore)2012;91:242. CrossRef

146. KamperL, BrandtA, ScharwächterC, et al.MR evaluation of retroperitoneal fibrosis. Rofo2011;183:721. CrossRef

147. Tobias‐MachadoM, CorreaW, KorkesF, et al.Transmesocolic ureteral intraperitonealization: a new approach for laparoscopic treatment of retroperitoneal fibrosis. J Laparoendosc Adv Surg Tech A2011;21:341. CrossRef

148. KermaniT, CrowsonC, AchenbachS, et al.Idiopathic retroperitoneal fibrosis: a retrospective review of clinical presentation, treatment, and outcomes. Mayo Clin Proc2011;86:297. CrossRef

149. KeehnA, MufarrijP, StifelmanM. Robotic ureterolysis for relief of ureteral obstruction from retroperitoneal fibrosis. Urology2011;77:1370. CrossRef

150. HaY, JungS, LeeK, et al.Retroperitoneal fibrosis in 27 Korean patients: single center experience. J Korean Med Sci2011;26:985. CrossRef

151. Sili ScavalliA, Di RoccoG, GiannottiD, et al.Two‐years follow‐up of low‐dose methotrexate and 6‐methylprednisolone therapy in a patient with idiopathic retroperitoneal fibrosis. Eur Rev Med Pharmacol Sci2012;16:2171.

152. KardarA, KattanS, LindstedtE, et al.Steroid therapy for idiopathic retroperitoneal fibrosis: dose and duration. J Urol2002;168:550. CrossRef

153. ScheelPJJr, PicciniJ, RahmanM, et al.Combined prednisone and mycophenolate mofetil treatment for retroperitoneal fibrosis. J Urol2007;178:140. CrossRef

154. PuceR, PorcaroA, CurtiP, et al.Treatment of retroperitoneal fibrosis with tamoxifen: case report and review of literature. Arch Esp Urol2000;53:184.

155. WanN, JiaoY. Non‐Hodgkin lymphoma mimics retroperitoneal fibrosis. BMJ Case Rep2013;2013 pii:bcr2013010433.

156. LimC, CooperC, DelpradoW, et al.Retroperitoneal inflammatory liposarcoma in a patient with non‐hodgkin lymphoma: a report highlighting diagnostic pitfalls. Patholog Res Int2010;2010:505436.

157. ESMO / European Sarcoma Network Working Group. Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow‐up. Ann Oncol2012;23:92. CrossRef

158. BrennanM. Sarcoma: primary retroperitoneal sarcoma‐ predicting survival. Nat Rev Clin Oncol2013;10:309. CrossRef

159. PickhardtP, BhallaS. Primary neoplasms of peritoneal and sub‐peritoneal origin: CT findings. Radiographics2005;25:983. CrossRef

160. RosenkrantzA, SpielerB, SeussC, et al.Utility of MRI features for differentiation of retroperitoneal fibrosis and lymphoma. AJR Am J Roentgenol2012;199:118. CrossRef

161. NishinoM, HayakawaK, MinamiM, et al.Primary retroperitoneal neoplasms: CT and MR imaging findings with anatomic and pathologic diagnostic clues. Radiographics2003;23:45. CrossRef

162. GronchiA, MiceliR, ShurellE, et al.Outcome prediction in primary resected retroperitoneal soft tissue sarcoma: histology‐specific overall survival and disease‐free survival nomograms built on major sarcoma center data sets. J Clin Oncol2013;31:1649. CrossRef

163. HaniballJ, SumathiV, KindblomL, et al.Prognostic factors and metastatic patterns in primary myxoid/round cell liposarcoma. Sarcoma2011;2011:538085. CrossRef

164. SivriogluA, SaglamM, DeveerM, et al.Another reason for abdominal pain: mesenteric panniculitis. BMJ Case Rep2013;2013 pii: bcr2013009305.

165. McLaughlinP, FilipponeA, MaherM. The “misty mesentery”: mesenteric panniculitis and its mimics. AJR Am J Roentgenol2013;200:W116. CrossRef

166. GaylisH, IsaacsonC, DeckerG. Mesenteric panniculitis presenting as abdominal aortic aneurysms. Surgery1973;74:626.

167. MacariM, HinesJ, BalthazarE, et al.Mesenteric adenitis: CT diagnosis of primary versus secondary causes, incidence, and clinical significance in pediatric and adult patients. AJR Am J Roentgenol2002;178:853. CrossRef

168. SatoM, IshidaH, KonnoK, et al.Mesenteric panniculitis: sonographic findings. Abdom Imaging2000;25:142. CrossRef

169. TytgatG, RoozendaalK, WinterW, et al.Successful treatment of a patient with retractile mesenteritis with prednisone and azathioprine. Gastroenterology1980;79:352.

170. BushR, HammarSJr, RudolphR. Sclerosing mesenteritis: response to cyclophosphamide. Arch Intern Med1986;146:503. CrossRef

171. MazureR, Fernandez MartyP, NiveloniS, et al.Successful treatment of retractile mesenteritis with oral progesterone. Gastroenterology1998;114:1313. CrossRef

172. ZhuH, ChenH, ZhangS, et al.Intra‐abdominal fibromatosis: differentiation from gastrointestinal stromal tumour based on biphasic contrast‐enhanced CT findings. Clin Radiol2013;68:1133. CrossRef

173. VaswaniB, ShahM, ShahP, et al.Giant mesenteric fibromatosis in Gardner's syndrome. Indian J Cancer2011;48:140. CrossRef

174. NaylorE, GardnerE, RichardsR. Desmoid tumors and mesenteric fibromatosis in Gardnerês syndrome: report of kindred 109. Arch Surg1979;114:1181. CrossRef

175. KoSF, LinJW, NgSH, et al.Spontaneous isolated mesenteric fibromatosis: sonographic and computed tomographic findings with pathologic correlation. Ultrasound Med Biol2006;32:1141. CrossRef

176. RosonN, GarrigaV, CuadradoM, et al.Sonographic findings of mesenteric panniculitis: correlation with CT and literature review. J Clin Ultrasound2006;34:169. CrossRef

177. GallettoP, LeozM, CastellsA, et al.Intraabdominal desmoid tumors in familial adenomatous polyposis. Gastroenterol Hepatol2013;36:580. CrossRef

178. SturtN, PhillipsR, ClarkS. High‐dose tamoxifen and sulindac as first‐line treatment for desmoid tumors. Cancer2004;101:652. CrossRef

179. CragoA, DentonB, SalasS, et al.A prognostic nomogram for prediction of recurrence in desmoid fibromatosis. Ann Surg2013;258:347. CrossRef

180. TeshimaM, IwaeS, HirayamaY, et al.Nonsteroidal anti‐inflammatory drug treatment for desmoid tumor recurrence after surgery. Otolaryngol Head Neck Surg2012;147:978. CrossRef

181. LonghiA, ErraniC, BattagliaM, et al.Aggressive fibromatosis of the neck treated with a combination of chemotherapy and indomethacin. Ear Nose Throat J2011;90:E11.

182. CostaL, CezanaL, OliveiraT, et al.Successful treatment of an intra‐abdominal desmoid tumor with irinotecan, fluorouracil, and leucovorin plus bevacizumab in a patient with familial adenomatous polyposis. Int J Colorectal Dis2012;27:257. CrossRef

183. GounderM, LefkowitzR, KeohanM, et al.Activity of Sorafenib against desmoid tumor/deep fibromatosis. Clin Cancer Res2011;17:4082. CrossRef

184. NamS, KimD, KimS, et al.The surgical experience for retroperitoneal, mesenteric and omental cyst in children. J Korean Surg Soc2012;83:102. CrossRef

185. LinJ, FisherJ, CatyM. Newborn intraabdominal cystic lymphatic malformations. Semin Pediatr Surg2000;9:141. CrossRef

186. GuptaRK, SahS, SahPL, et al.Congenital omental cyst. BMJ Case Rep2012;2012 pii:bcr2012006643.

187. AyyappanA, JhaveriK, HaiderM. Radiological assessment of mesenteric and retroperitoneal cysts in adults: is there a role for chemical shift MRI?Clin Imaging2011;35:127. CrossRef

188. DequanterD, LefebvreJ, BelvaP, et al.Mesenteric cysts: a case treated by laparoscopy and a review of the literature. Surg Endosc2002;16:1493. CrossRef

189. TranN, NguyenT. Laparoscopic management of abdominal lymphatic cyst in children. J Laparoendosc Adv Surg Tech A2012;22:505. CrossRef

190. CadedduM, MamazzaJ, SchlachtaC, et al.Laparoscopic excision of retroperitoneal tumors: technique and review of the laparoscopic experience. Surg Laparosc Endosc Percutan Tech2001;11:144.

191. ConzoG, VaccaR, Grazia EspositoM, et al.Laparoscopic treatment of an omental cyst: a case report and review of the literature. Surg Laparosc Endosc Percutan Tech2005;15:33. CrossRef

192. MasonJ, SoperN, BruntL. Laparoscopic excision of mesenteric cysts: a report of two cases. Surg Laparosc Endosc Percutan Tech2001;11:382. CrossRef

193. HibiT, OjimaH, SakamotoY, et al.A solid pseudopapillary tumor arising from the greater omentum followed by multiple metastases with increasing malignant potential. J Gastroenterol2006;41:276. CrossRef

194. ZongL, ChenP, WangG, et al.Giant solitary fibrous tumor arising from greater omentum. World J Gastroenterol2012;18:6515. CrossRef

195. ModlinI, ShapiroM, KiddM. Carcinoid tumors and fibrosis: an association with no explanation. Am J Gastroenterol2004;99:2466. CrossRef

196. CoanK, GrayR, SchlinkertR, et al.Metastatic carcinoid tumors–are we making the cut?Am J Surg2013;205:642. CrossRef

197. VerweijJ, CasaliP, ZalcbergJ, et al.Progression‐free survival in gastrointestinal stromal tumours with high‐dose imatinib: randomised trial. Lancet2004;364:1127. CrossRef

198. LinchM, ClausJ, BensonC. Update on imatinib for gastrointestinal stromal tumors: duration of treatment. Onco Targets Ther2013;6:1011.